United Health Products, Inc.
UEEC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 63,459.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | 50.3% | 57.6% |
| R&D Expenses | $0 | $1 | $1 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $30 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $3 | $30 |
| Operating Income | -$2 | -$2 | -$3 | -$30 |
| % Margin | – | – | -7,472.1% | -50,509,550.8% |
| Other Income/Exp. Net | $0 | -$0 | $1 | -$1 |
| Pre-Tax Income | -$2 | -$3 | -$2 | -$31 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$3 | -$2 | -$31 |
| % Margin | – | – | -4,500% | -51,778,276.3% |
| EPS | -0.008 | -0.011 | -0.007 | -0.14 |
| % Growth | 26.4% | -50.7% | 94.8% | – |
| EPS Diluted | -0.008 | -0.011 | -0.007 | -0.14 |
| Weighted Avg Shares Out | 249 | 239 | 230 | 226 |
| Weighted Avg Shares Out Dil | 249 | 239 | 230 | 226 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$3 | -$2 | -$30 |
| % Margin | – | – | -4,278.9% | -50,730,393.2% |